Unlock New Opportunities: Partner with a Brazilian Distributor

Sustainable growth in MedTech and healthcare requires more than innovative products; it demands strategic marketing. From bridging product-market gaps to refreshing brand messaging, learn the essential strategies for achieving long-term success and staying competitive in the dynamic MedTech landscape in our latest article.

We are excited to exhibit at Medica in Düsseldorf, Germany, again this year to showcase our leading MedTech platform that makes it easier for distributors to find and connect with innovative manufacturers and discover new solutions for their markets.

Press Release. Bristol, 17th September 2024 – SehaMed, a leading global MedTech platform, is delighted to announce its official partnership with Abraidi (Associação Brasileira de Importadores e Distribuidores de Produtos para Saúde), with the collaboration initiated by LINK HBB, a strategic partner of both SehaMed and Abraidi. This partnership aims to provide Brazilian MedTech distributors with easier access to high-quality and innovative medical technologies from Europe and the US, while also increasing market access for SehaMed’s manufacturing partners.

Building strong customer relationships in MedTech and healthcare is crucial for long-term success. Emotional narratives that highlight real-life impacts foster authentic connections, drive loyalty, and expand reach through word-of-mouth. This is the 2nd article in our new MedTech marketing series in collaboration with Surreal. Discover the power of human stories in marketing!

Postpartum Haemorrhage (PPH) affects millions of women every year and accounts for over 20% of all maternal deaths reported globally. The Second Global Call from the World Health Organisation is out to develop a robust evidence base for the definition of postpartum Haemorrhage (PPH). How much blood loss is too much and when do we define PPH to promote early intervention. There is substantial disagreement on several domains, including the amount of blood loss, time of measurement, inclusion of clinical signs and symptoms of haemodynamic instability, and mode of delivery.
 

As the Saudi Arabian healthcare market continues to expand under the ambitious Saudi Vision 2030, European and US medical device manufacturers are increasingly setting their sights on the region.